Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

(E)-(1S,4S,10S,21R)-7-[(Z)-ethylidene]-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23- tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone

EU orphan designation number: EU/3/05/328   
Active ingredient: (E)-(1S,4S,10S,21R)-7-[(Z)-ethylidene]-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23- tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone
Indication: Treatment of peripheral T-cell lymphoma (nodal, other extranodal and leukaemic/disseminated)
Sponsor: Celgene Europe Limited
1 Longwalk Road, Stockley Park, Uxbridge, Middlesex UB11 1DB, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
7/11/2005 Orphan designation EMEA/OD/056/05 (2005)4352 of 28/10/2005
23/10/2008 Transfer of orphan designation EMEA/OD/056/05/T/01 (2008)6244 of 21/10/2008
30/09/2010 Transfer of orphan designation EMEA/OD/056/05/T/02 (2010)6803 of 28/09/2010
30/05/2011 Change of name and/or address of sponsor EMEA/OD/056/05